Status of work in March
AOTMiT begins work on the Ministry of Health’s orders in March:
- Opdivo (nivolumab) in the treatment of urothelial cancer patients
- Cibinqo (abrocitinib) in the treatment of patients with atopic dermatitis
- Livmarli (Maralixibat chloride) in the treatment of patients with Alagille syndrome
The listed orders are available on the AOTMiT Public Information Bulletin.